Disease

Gastric Cancer

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 1 TRIAL

Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1b trial registration with no results posted; it describes a planned open-label, single-arm safety and dose-escalation study in early-stage drug development.

PreliminaryNCT07806500 R01 Gastric Cancer

Reported

Planned enrollment18

PhasePhase 1b

Dose escalation levels240, 320, and 400 mg BID

AUG 26, 2026 · JOURNAL ARTICLE

Early Gastric Cancer Detected During 15-year Surveillance After Ménétrier Disease Remission and Successfully Treated With Endoscopic Submucosal Dissection: A Case Report.

Den Open

A single case report documenting early gastric cancer detection and successful endoscopic treatment during surveillance of a patient with remote Ménétrier disease remission; raises questions about long-term cancer risk and surveillance strategy but provides no comparative data or population-level evidence.

PreliminaryMasahiro Yamada Takehito Naito Hideko Yamamoto

Reported

Time to cancer detection15 years

Surveillance intervalAnnual esophagogastroduodenoscopy

AUG 7, 2026 · INTERVENTIONAL STUDY

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

ClinicalTrials.gov

This is a registered but actively recruiting trial with no reported results; the study design is sound but outcomes remain unposted in the registry.

PreliminaryNCT04284943 Diabetes Mellitus, Type 2 Korea University Anam Hospital

Reported

Estimated enrollment120

Primary outcome measureHbA1c < 6.5% at 12 months

Follow-up duration12 months